- Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer
-
Kim K, Hwangbo S, Kim H, Kim YB, No JH, Suh DHx, Park T
- KMID: 2536985
- J Gynecol Oncol.
- 2022 May;33(3):e27.
- doi: 10.3802/jgo.2022.33.e27
Objective The need to perform genetic sequencing to diagnose the polymerase epsilon exonuclease (POLE) subtype of endometrial cancer (EC) hinders the adoption of molecular classification. We investigated clinicopathologic and protein markers... -
- CITED
-
- Close
- SHARE
-
- Close
